NCT06143930

Brief Summary

Traditional physical therapy resisted training for people with MS have been shown to be beneficial; however, their usefulness has been limited by fatigue. The effect of blood flow restriction on strength and other measures of physical function was demonstrated in healthy populations and those with chronic disease. This study may add missing information to the existing literature and suggests directions for research on the effectiveness of BFR training on individuals with relapsing and remitting MS.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
48

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2023

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2023

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

October 25, 2023

Completed
28 days until next milestone

First Posted

Study publicly available on registry

November 22, 2023

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2024

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2024

Completed
Last Updated

November 22, 2023

Status Verified

November 1, 2023

Enrollment Period

9 months

First QC Date

October 25, 2023

Last Update Submit

November 16, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • muscle strength

    measure maximal torque production at a specified velocity of limb movement. measure torque of hip flexors , extensors , knee flexors and extensors

    one week after the end of treatment

Secondary Outcomes (1)

  • gait performance by Two-dimensional (2D) Motion Analysis system

    one week after the end of treatment

Study Arms (2)

The control group (A) will receive therapeutic strengthening training program for lower extremities.

ACTIVE COMPARATOR

low intensity strengthening exercise program

Other: strengthening ex

The study group (B) will receive strengthening training with blood flow restriction

ACTIVE COMPARATOR

the same selected low intensity resisted exercise program as group (A) with blood flow restriction

Other: strengthening ex with BFR training

Interventions

Therapeutic strengthening training with blood flow restriction of trained limb.

The study group (B) will receive strengthening training with blood flow restriction

Therapeutic strengthening training program for lower extremities.

The control group (A) will receive therapeutic strengthening training program for lower extremities.

Eligibility Criteria

Age18 Years - 45 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Patients were diagnosed with MS by a neurologist according to McDonald's criteria 2010
  • Expanded Disability Status Scale (EDSS) scores ranging from 2.5 to 5.5 .
  • Patient able to walk 100 meters or more.
  • No change within MS specific medication three months from the study.
  • Last Ms Attack from more than two months.

You may not qualify if:

  • Multiple sclerosis patients with other neurological or orthopedic problems.
  • Multiple sclerosis patients with systemic problems (cardiovascular or pulmonary diseases…).
  • Patients with cognitive impairment.
  • Pregnant female patients.
  • Patients in acute relapse stage.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of physical therapy

Giza, +20, Egypt

RECRUITING

Study Officials

  • Habiba Zienhom

    Cairo University

    PRINCIPAL INVESTIGATOR
  • Dr.Moshera Hassan Darwish, professor

    professor of physical therapy,aculty of Physical therapy ,Cairo university

    STUDY DIRECTOR
  • Dr Mohamed Soliman Al-Tamawy, professor

    professor of Neurology, Faculty of Medicine,Cairo university

    STUDY DIRECTOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

October 25, 2023

First Posted

November 22, 2023

Study Start

July 1, 2023

Primary Completion

April 1, 2024

Study Completion

July 1, 2024

Last Updated

November 22, 2023

Record last verified: 2023-11

Data Sharing

IPD Sharing
Will not share

Locations